Tribby Calvin P, Alismail Sarah, Nukavarapu Nivedita, Yang Jiue-An, Jankowska Marta M
Department of Population Sciences, Lippman Graff Building, Beckman Research Institute, City of Hope, Office #B123, 1500 E Duarte Rd, Duarte, CA, 91010, USA.
Windreich Department of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai, Sinai, NYC, USA.
J Cancer Surviv. 2024 Dec 19. doi: 10.1007/s11764-024-01729-6.
This paper estimated overall, by sex, and by race and ethnicity walking behaviors in the cancer survivor population, where prevalence is not known, compared to those without cancer.
Data from the 2015 and 2020 National Health Interview Survey (n = 54,542) were used to estimate walking behaviors. Multivariable logistic regression models estimated walking behavior prevalence with predictive margins and volume of weekly minutes overall and stratified by sex and race/ethnicity. Walking behaviors for breast and prostate cancer survivors were also examined.
There were no significant differences in adjusted prevalence for walking behaviors overall or by race/ethnicity for women. However, there were significant differences for men, with cancer survivors' any reported walking at 62.6% (95% CI: 60.1, 65.4) compared to men without cancer, 65.9% (95% CI: 65.1%, 66.8%) (p = 0.02). There was also a difference in transportation only walking for men, with cancer survivors reporting 6.8% (95% CI: 5.5%, 8.2%), compared to men without cancer, 9.1% (8.5%, 9.6%) (p = 0.008); a similar pattern was observed for transportation walking for non-Hispanic white men. There were no differences in walking prevalence among breast cancer survivors, but overall prostate cancer survivors reported less walking for both purposes as did non-Hispanic white survivors. Leisure walking volume for cancer survivors, both women and men, was higher than for those without cancer. Median leisure walking minutes for non-Hispanic white women, 120 min (95% CI: 120, 140) was higher than those without cancer, 105 min (95% CI: 105, 120) (p = 0.002). Median leisure walking minutes for non-Hispanic white men, 120 min (95% CI: 120, 140), was higher than those without cancer, 100 min (95% CI: 100, 105) (p = 0.001).
Overall, there are no significant differences in walking prevalence for women, but men cancer survivors reported less overall walking, walking for transportation, or walking for both purposes. However, volume of leisure walking was higher for cancer survivors compared to those without cancer.
For cancer survivors, this suggests that even though prevalence of leisure walking was similar, volume of weekly minutes was higher compared to those without cancer. This suggests that for cancer survivors, leisure walking is an accessible and important source of physical activity.
本文按性别、种族和族裔估算了癌症幸存者群体中的步行行为总体情况，该群体的步行行为患病率未知，并将其与非癌症患者群体进行了比较。
使用2015年和2020年全国健康访谈调查（n = 54,542）的数据来估算步行行为。多变量逻辑回归模型通过预测边际和每周总体分钟数估算步行行为患病率，并按性别和种族/族裔进行分层。还对乳腺癌和前列腺癌幸存者的步行行为进行了研究。
女性总体步行行为或按种族/族裔调整后的患病率无显著差异。然而，男性存在显著差异，癌症幸存者中报告有任何步行行为的比例为62.6%（95%置信区间：60.1，65.4），而非癌症男性为65.9%（95%置信区间：65.1%，66.8%）（p = 0.02）。男性仅用于交通目的的步行也存在差异，癌症幸存者报告的比例为6.8%（95%置信区间：5.5%，8.2%），而非癌症男性为9.1%（8.5%，9.6%）（p = 0.008）；非西班牙裔白人男性用于交通目的的步行也观察到类似模式。乳腺癌幸存者的步行患病率无差异，但总体而言，前列腺癌幸存者用于两种目的的步行均少于非西班牙裔白人幸存者。癌症幸存者（无论男女）的休闲步行量高于非癌症患者。非西班牙裔白人女性的休闲步行中位数分钟数为120分钟（95%置信区间：120，140），高于非癌症女性的105分钟（95%置信区间：105，120）（p = 0.002）。非西班牙裔白人男性的休闲步行中位数分钟数为120分钟（95%置信区间：120，140），高于非癌症男性的100分钟（95%置信区间：100，105）（p = 0.001）。
总体而言，女性的步行患病率无显著差异，但男性癌症幸存者报告的总体步行、交通步行或两种目的的步行均较少。然而，癌症幸存者的休闲步行量高于非癌症患者。
对于癌症幸存者来说，这表明尽管休闲步行的患病率相似，但每周的分钟数高于非癌症患者。这表明对于癌症幸存者而言，休闲步行是一种可及且重要的身体活动来源。
